PanCareSurPass Project HL7 FHIR Implementation Guide
0.2.0 - CI Build 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

: MedicationAdministration: Chemotherapy Hulafe Ciclofosfamide - JSON Representation

Raw json | Download


{
  "resourceType" : "MedicationAdministration",
  "id" : "ChemoHulafe-1-Ciclofosfamide",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.eu/fhir/ig/pcsp/StructureDefinition/MedicationAdministration-eu-pcsp"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationAdministration ChemoHulafe-1-Ciclofosfamide</b></p><a name=\"ChemoHulafe-1-Ciclofosfamide\"> </a><a name=\"hcChemoHulafe-1-Ciclofosfamide\"> </a><a name=\"ChemoHulafe-1-Ciclofosfamide-en-US\"> </a><p><b>Act Location</b>: <a href=\"Location-ChemoHulafe-1-Location.html\">Location Hospital la Fe</a></p><p><b>Resource related information</b>: <a href=\"Observation-ChemoHulafe-1-Ciclofosfamide-dose.html\">Observation Cumulative dose received by a patient for a specific drug.</a></p><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:{http://www.whocc.no/atc L01AA01}\">cyclophosphamide</span></p><p><b>subject</b>: <a href=\"Patient-PatientHulafe-1.html\">NOMBRE APELLIDO1 APELLIDO2(anonymous) Female, DoB: 2005-07-01 ( urn:oid:2.16.724.4.10.50.200#123456789\u00a0(use:\u00a0official,\u00a0))</a></p><p><b>effective</b>: 2012-08-08 --&gt; 2012-10-11</p><p><b>reasonReference</b>: <a href=\"Condition-PrimaryCancerHulafe-1.html\">Condition un-encoded</a></p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.eu/fhir/ig/pcsp/StructureDefinition/event-location",
      "valueReference" : {
        🔗 "reference" : "Location/ChemoHulafe-1-Location"
      }
    },
    {
      "url" : "http://hl7.eu/fhir/ig/pcsp/StructureDefinition/resource-relatedInfo",
      "valueReference" : {
        🔗 "reference" : "Observation/ChemoHulafe-1-Ciclofosfamide-dose"
      }
    }
  ],
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://www.whocc.no/atc",
        "code" : "L01AA01",
        "display" : "cyclophosphamide"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/PatientHulafe-1",
    "type" : "Patient"
  },
  "effectivePeriod" : {
    "start" : "2012-08-08",
    "end" : "2012-10-11"
  },
  "reasonReference" : [
    {
      🔗 "reference" : "Condition/PrimaryCancerHulafe-1"
    }
  ]
}